Document is current
Any future updates will be listed below
-
Authors
Van den Broucke, Evelyne
Deleenheer, Barbara https://orcid.org/0000-0003-3733-2378
Meulemans, Ann https://orcid.org/0000-0003-3938-2408
Vanderstappen, Julie
Pauwels, Nelle
Cosaert, Katrien
Spriet, Isabel https://orcid.org/0000-0001-6342-0676
Van Veer, Hans https://orcid.org/0000-0003-1153-8298
Vangoitsenhoven, Roman https://orcid.org/0000-0003-3523-669X
Sabino, João https://orcid.org/0000-0002-8892-7075
Declercq, Peter https://orcid.org/0000-0002-6338-2355
Vanuytsel, Tim https://orcid.org/0000-0001-8728-0903
Quintens, Charlotte https://orcid.org/0000-0002-6072-2596
- License Information
-
More Information
Article History
Received: 7 February 2022
Accepted: 16 May 2022
First Online: 9 July 2022
Declarations
:
: Approval by the education-support committee of the Catholic University of Leuven (KU Leuven) (MP014038) was granted.
: The recommendations generated by the OLIVE TREE were provided directly to the prescribing physician, who finally had to decide on PN prescribing. Patients were therefore not obliged to provide informed consent.
: The recommendations generated by the OLIVE TREE were provided directly to the prescribing physician, who finally had to decide on PN prescribing. Patients were therefore not obliged to provide informed consent.
: B. Deleenheer: None Declared, E. Van den Broucke: None Declared, A. Meulemans: None Declared, J. Vanderstappen: None Declared, N. Pauwels: None Declared, K. Cosaert: None Declared, I. Spriet: None Declared, H. Van Veer Speakers Bureau of: Fresenius, R. Vangoitsenhoven: None Declared, J. Sabino: Consultant for Janssen, Speakers Bureau of Abbvie, Falk and Takeda., P. Declercq: None Declared, T. Vanuytsel: None Declared, C. Quintens: None Declared.
